메뉴 건너뛰기




Volumn 3, Issue 3, 2006, Pages 262-269

Approaches to improving health status in chronic obstructive pulmonary disease: One or several?

Author keywords

Outcome measures; Pulmonary rehabilitation; Systemic inflammation; Therapy

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FORMOTEROL; IPRATROPIUM BROMIDE; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT; PLACEBO; SALMETEROL;

EID: 33646381629     PISSN: 15463222     EISSN: 15463222     Source Type: Journal    
DOI: 10.1513/pats.200511-118SF     Document Type: Conference Paper
Times cited : (12)

References (100)
  • 1
    • 0032500727 scopus 로고    scopus 로고
    • Outcomes research: Measuring the end results of health care
    • Clancy CM, Eisenberg JM. Outcomes research: measuring the end results of health care. Science 1998;282:245-246.
    • (1998) Science , vol.282 , pp. 245-246
    • Clancy, C.M.1    Eisenberg, J.M.2
  • 2
    • 0038440780 scopus 로고    scopus 로고
    • The assessment of health status among patients with COPD
    • Curtis JR, Patrick DL. The assessment of health status among patients with COPD. Eur Respir J Suppl 2003;41:36s-45s.
    • (2003) Eur Respir J Suppl , vol.41
    • Curtis, J.R.1    Patrick, D.L.2
  • 3
    • 0031992445 scopus 로고    scopus 로고
    • Comparing generic and disease-specific measures of physical and role functioning: Results from the Veterans Health Study
    • Ren XS, Kazis L, Lee A, Miller DR, Clark JA, Skinner K, Rogers W. Comparing generic and disease-specific measures of physical and role functioning: results from the Veterans Health Study. Med Care 1998;36:155-166.
    • (1998) Med Care , vol.36 , pp. 155-166
    • Ren, X.S.1    Kazis, L.2    Lee, A.3    Miller, D.R.4    Clark, J.A.5    Skinner, K.6    Rogers, W.7
  • 5
    • 0026871146 scopus 로고
    • A self-complete measure of health status for chronic airflow limitation: The St. George's Respiratory Questionnaire
    • Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-1327.
    • (1992) Am Rev Respir Dis , vol.145 , pp. 1321-1327
    • Jones, P.W.1    Quirk, F.H.2    Baveystock, C.M.3    Littlejohns, P.4
  • 6
    • 0033017445 scopus 로고    scopus 로고
    • Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation
    • Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999;52:187-192.
    • (1999) J Clin Epidemiol , vol.52 , pp. 187-192
    • Guyatt, G.H.1    King, D.R.2    Feeny, D.H.3    Stubbing, D.4    Goldstein, R.S.5
  • 7
    • 0031945935 scopus 로고    scopus 로고
    • Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease
    • Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:785-790.
    • (1998) Am J Respir Crit Care Med , vol.157 , pp. 785-790
    • Hajiro, T.1    Nishimura, K.2    Tsukino, M.3    Ikeda, A.4    Koyama, H.5    Izumi, T.6
  • 8
    • 0031768356 scopus 로고    scopus 로고
    • Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease
    • Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1185-1189.
    • (1998) Am J Respir Crit Care Med , vol.158 , pp. 1185-1189
    • Hajiro, T.1    Nishimura, K.2    Tsukino, M.3    Ikeda, A.4    Koyama, H.5    Izumi, T.6
  • 9
    • 0024427075 scopus 로고
    • Measuring functional status in chronic lung disease: Conclusions from a randomized control trial
    • Guyatt GH, Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med 1989;83:293-297.
    • (1989) Respir Med , vol.83 , pp. 293-297
    • Guyatt, G.H.1    Townsend, M.2    Keller, J.3    Singer, J.4    Nogradi, S.5
  • 10
    • 0024852022 scopus 로고
    • Measurement of health status: Ascertaining the minimal clinically important difference
    • Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-415.
    • (1989) Control Clin Trials , vol.10 , pp. 407-415
    • Jaeschke, R.1    Singer, J.2    Guyatt, G.H.3
  • 11
    • 0030603333 scopus 로고    scopus 로고
    • Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease
    • Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996;348:1115-1119.
    • (1996) Lancet , vol.348 , pp. 1115-1119
    • Lacasse, Y.1    Wong, E.2    Guyatt, G.H.3    King, D.4    Cook, D.J.5    Goldstein, R.S.6
  • 12
    • 0025886867 scopus 로고
    • The St. George's Respiratory Questionnaire
    • Jones PW, Quirk FH, Baveystock CM. The St. George's Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25-31. [Discussion, 33-37.]
    • (1991) Respir Med , vol.85 , Issue.SUPPL. B , pp. 25-31
    • Jones, P.W.1    Quirk, F.H.2    Baveystock, C.M.3
  • 13
    • 0030903442 scopus 로고    scopus 로고
    • Quality of life changes in COPD patients treated with salmeterol
    • Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997;155:1283-1289.
    • (1997) Am J Respir Crit Care Med , vol.155 , pp. 1283-1289
    • Jones, P.W.1    Bosh, T.K.2
  • 14
    • 0024854562 scopus 로고
    • Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation
    • Jones PW, Baveystock CM, Littlejohns P. Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation. Am Rev Respir Dis 1989;140:1538-1543.
    • (1989) Am Rev Respir Dis , vol.140 , pp. 1538-1543
    • Jones, P.W.1    Baveystock, C.M.2    Littlejohns, P.3
  • 15
    • 0028588741 scopus 로고
    • Using quality of life information to set priorities in health policy
    • Kaplan R. Using quality of life information to set priorities in health policy. Soc Indic Res 1994;33:121-163.
    • (1994) Soc Indic Res , vol.33 , pp. 121-163
    • Kaplan, R.1
  • 16
    • 0038440793 scopus 로고    scopus 로고
    • Methodological issues in evaluating measures of health as outcomes for COPD
    • Jones PW, Kaplan RM. Methodological issues in evaluating measures of health as outcomes for COPD. Eur Respir J Suppl 2003;41:13s-18s.
    • (2003) Eur Respir J Suppl , vol.41
    • Jones, P.W.1    Kaplan, R.M.2
  • 17
    • 0035035768 scopus 로고    scopus 로고
    • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary
    • Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
    • (2001) Am J Respir Crit Care Med , vol.163 , pp. 1256-1276
    • Pauwels, R.A.1    Buist, A.S.2    Calverley, P.M.3    Jenkins, C.R.4    Hurd, S.S.5
  • 18
    • 0023903301 scopus 로고
    • Detection of emphysema with computed tomography: Correlation with pulmonary function tests and chest radiography
    • Sanders C, Nath PH, Bailey WC. Detection of emphysema with computed tomography: correlation with pulmonary function tests and chest radiography. Invest Radiol 1988;23:262-266.
    • (1988) Invest Radiol , vol.23 , pp. 262-266
    • Sanders, C.1    Nath, P.H.2    Bailey, W.C.3
  • 19
    • 0025764657 scopus 로고
    • High resolution computed tomography in adult cystic fibrosis patients with mild lung disease
    • Santis G, Hodson ME, Strickland B. High resolution computed tomography in adult cystic fibrosis patients with mild lung disease. Clin Radiol 1991;44:20-22.
    • (1991) Clin Radiol , vol.44 , pp. 20-22
    • Santis, G.1    Hodson, M.E.2    Strickland, B.3
  • 20
    • 0030470881 scopus 로고    scopus 로고
    • New developments in anticholinergic drugs
    • Barnes P. New developments in anticholinergic drugs. Eur Respir Rev 1996;6:290-294.
    • (1996) Eur Respir Rev , vol.6 , pp. 290-294
    • Barnes, P.1
  • 21
    • 0028827084 scopus 로고
    • Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
    • American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-S121.
    • (1995) Am J Respir Crit Care Med , vol.152
  • 22
    • 0041853629 scopus 로고    scopus 로고
    • Bronchodilator reversibility testing in chronic obstructive pulmonary disease
    • Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW; for the ISOLDE Study Investigators. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003;58(8):659-664.
    • (2003) Thorax , vol.58 , Issue.8 , pp. 659-664
    • Calverley, P.M.1    Burge, P.S.2    Spencer, S.3    Anderson, J.A.4    Jones, P.W.5
  • 24
    • 20144382361 scopus 로고    scopus 로고
    • Minimal clinically important differences in COPD lung function
    • Donohue J. Minimal clinically important differences in COPD lung function. COPD: J Chron Obstruct Pulmon Dis 2005;2:111-124.
    • (2005) COPD: J Chron Obstruct Pulmon Dis , vol.2 , pp. 111-124
    • Donohue, J.1
  • 25
    • 0030012048 scopus 로고    scopus 로고
    • Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease
    • Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:967-975.
    • (1996) Am J Respir Crit Care Med , vol.153 , pp. 967-975
    • Belman, M.J.1    Botnick, W.C.2    Shin, J.W.3
  • 26
    • 0032778472 scopus 로고    scopus 로고
    • Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease
    • O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:542-549.
    • (1999) Am J Respir Crit Care Med , vol.160 , pp. 542-549
    • O'Donnell, D.E.1    Lam, M.2    Webb, K.A.3
  • 28
    • 0036206421 scopus 로고    scopus 로고
    • Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation
    • Newton MF, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002;121:1042-1050.
    • (2002) Chest , vol.121 , pp. 1042-1050
    • Newton, M.F.1    O'Donnell, D.E.2    Forkert, L.3
  • 29
    • 0035691634 scopus 로고    scopus 로고
    • Evaluation of bronchodilator responses in patients with "irreversible" emphysema
    • O'Donnell DE, Forkert L, Webb KA. Evaluation of bronchodilator responses in patients with "irreversible" emphysema. Eur Respir J 2001;18:914-920.
    • (2001) Eur Respir J , vol.18 , pp. 914-920
    • O'Donnell, D.E.1    Forkert, L.2    Webb, K.A.3
  • 31
    • 0029936277 scopus 로고    scopus 로고
    • Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials
    • Rennard SI, Serby CW, Ghafouri M, Johnson PA, Friedman M. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials. Chest 1996;110:62-70.
    • (1996) Chest , vol.110 , pp. 62-70
    • Rennard, S.I.1    Serby, C.W.2    Ghafouri, M.3    Johnson, P.A.4    Friedman, M.5
  • 32
    • 0037425745 scopus 로고    scopus 로고
    • Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomised controlled trial
    • Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003;361:449-456.
    • (2003) Lancet , vol.361 , pp. 449-456
    • Calverley, P.1    Pauwels, R.2    Vestbo, J.3    Jones, P.4    Pride, N.5    Gulsvik, A.6    Anderson, J.7    Maden, C.8
  • 34
    • 0347473812 scopus 로고    scopus 로고
    • Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease
    • Calverley PM, Boonsawat W, Cseke Z, Zhong N, Peterson S, Olsson H. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003;22:912-919.
    • (2003) Eur Respir J , vol.22 , pp. 912-919
    • Calverley, P.M.1    Boonsawat, W.2    Cseke, Z.3    Zhong, N.4    Peterson, S.5    Olsson, H.6
  • 35
    • 0038366897 scopus 로고    scopus 로고
    • Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD
    • Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 2003;58:399-404.
    • (2003) Thorax , vol.58 , pp. 399-404
    • Brusasco, V.1    Hodder, R.2    Miravitlles, M.3    Korducki, L.4    Towse, L.5    Kesten, S.6
  • 38
    • 0034061777 scopus 로고    scopus 로고
    • Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease
    • Lams BE, Sousa AR, Rees PJ, Lee TH. Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000;15:512-516.
    • (2000) Eur Respir J , vol.15 , pp. 512-516
    • Lams, B.E.1    Sousa, A.R.2    Rees, P.J.3    Lee, T.H.4
  • 41
    • 0030071687 scopus 로고    scopus 로고
    • Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma
    • Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-534.
    • (1996) Am J Respir Crit Care Med , vol.153 , pp. 530-534
    • Keatings, V.M.1    Collins, P.D.2    Scott, D.M.3    Barnes, P.J.4
  • 42
    • 0036839767 scopus 로고    scopus 로고
    • Local and systemic inflammation in patients with chronic obstructive pulmonary disease: Soluble tumor necrosis factor receptors are increased in sputum
    • Vernooy JH, Kucukaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, Wouters EF. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002;166:1218-1224.
    • (2002) Am J Respir Crit Care Med , vol.166 , pp. 1218-1224
    • Vernooy, J.H.1    Kucukaycan, M.2    Jacobs, J.A.3    Chavannes, N.H.4    Buurman, W.A.5    Dentener, M.A.6    Wouters, E.F.7
  • 43
    • 0032696013 scopus 로고    scopus 로고
    • Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease
    • Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1635-1639.
    • (1999) Am J Respir Crit Care Med , vol.160 , pp. 1635-1639
    • Culpitt, S.V.1    Maziak, W.2    Loukidis, S.3    Nightingale, J.A.4    Matthews, J.L.5    Barnes, P.J.6
  • 44
    • 0036727142 scopus 로고    scopus 로고
    • Effects of fluticasone propionate on inflammatory cells in COPD: An ultrastructural examination of endobronchial biopsy tissue
    • Gizycki MJ, Hattotuwa KL, Barnes N, Jeffery PK. Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue. Thorax 2002;57:799-803.
    • (2002) Thorax , vol.57 , pp. 799-803
    • Gizycki, M.J.1    Hattotuwa, K.L.2    Barnes, N.3    Jeffery, P.K.4
  • 46
    • 0034643610 scopus 로고    scopus 로고
    • Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
    • Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000;320:1297-1303.
    • (2000) BMJ , vol.320 , pp. 1297-1303
    • Burge, P.S.1    Calverley, P.M.2    Jones, P.W.3    Spencer, S.4    Anderson, J.A.5    Maslen, T.K.6
  • 47
    • 0036153433 scopus 로고    scopus 로고
    • Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids
    • Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J 2002;19:182-191.
    • (2002) Eur Respir J , vol.19 , pp. 182-191
    • Barnes, P.J.1
  • 48
    • 0037180086 scopus 로고    scopus 로고
    • Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling
    • Roth M, Johnson PR, Rudiger JJ, King GG, Ge Q, Burgess JK, Anderson G, Tamm M, Black JL. Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 2002;360:1293-1299.
    • (2002) Lancet , vol.360 , pp. 1293-1299
    • Roth, M.1    Johnson, P.R.2    Rudiger, J.J.3    King, G.G.4    Ge, Q.5    Burgess, J.K.6    Anderson, G.7    Tamm, M.8    Black, J.L.9
  • 49
    • 0028264310 scopus 로고
    • Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
    • Allen & Hanburys Limited UK Study Group
    • Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994;344:219-224.
    • (1994) Lancet , vol.344 , pp. 219-224
    • Greening, A.P.1    Ind, P.W.2    Northfield, M.3    Shaw, G.4
  • 50
    • 1842370350 scopus 로고    scopus 로고
    • Effect of inhaled formoterol and budesonide on exacerbations of asthma
    • Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
    • Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-1411.
    • (1997) N Engl J Med , vol.337 , pp. 1405-1411
    • Pauwels, R.A.1    Lofdahl, C.G.2    Postma, D.S.3    Tattersfield, A.E.4    O'Byrne, P.5    Barnes, P.J.6    Ullman, A.7
  • 51
    • 0036899028 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease. 5: Systemic effects of COPD
    • Wouters EF. Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax 2002;57:1067-1070.
    • (2002) Thorax , vol.57 , pp. 1067-1070
    • Wouters, E.F.1
  • 54
    • 0034881290 scopus 로고    scopus 로고
    • The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: A randomized controlled trial
    • Finnerty JP, Keeping I, Bullough I, Jones J. The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial. Chest 2001;119:1705-1710.
    • (2001) Chest , vol.119 , pp. 1705-1710
    • Finnerty, J.P.1    Keeping, I.2    Bullough, I.3    Jones, J.4
  • 56
    • 0033804346 scopus 로고    scopus 로고
    • Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease
    • Mostert R, Goris A, Weling Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000;94:859-867.
    • (2000) Respir Med , vol.94 , pp. 859-867
    • Mostert, R.1    Goris, A.2    Weling Scheepers, C.3    Wouters, E.F.4    Schols, A.M.5
  • 57
    • 2942720459 scopus 로고    scopus 로고
    • Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD
    • Franssen FM, Broekhuizen R, Janssen PP, Wouters EF, Schols AM. Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD. Chest 2004;125:2021-2028.
    • (2004) Chest , vol.125 , pp. 2021-2028
    • Franssen, F.M.1    Broekhuizen, R.2    Janssen, P.P.3    Wouters, E.F.4    Schols, A.M.5
  • 61
    • 0028863598 scopus 로고
    • The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation
    • O'Donnell D, McGuire M, Samis L, Webb KA. The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med 1995;152:2005-2013.
    • (1995) Am J Respir Crit Care Med , vol.152 , pp. 2005-2013
    • O'Donnell, D.1    McGuire, M.2    Samis, L.3    Webb, K.A.4
  • 62
    • 0030042996 scopus 로고    scopus 로고
    • Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patient with COPD
    • Maltais F, Simard A, Simard C, Jobin J, Desgagnés P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patient with COPD. Am J Respir Crit Care Med 1996;153:288-293.
    • (1996) Am J Respir Crit Care Med , vol.153 , pp. 288-293
    • Maltais, F.1    Simard, A.2    Simard, C.3    Jobin, J.4    Desgagnés, P.5    LeBlanc, P.6
  • 63
    • 0031685110 scopus 로고    scopus 로고
    • Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease
    • Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, Belleau R, Maltais F. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998;30:1467-1474.
    • (1998) Med Sci Sports Exerc , vol.30 , pp. 1467-1474
    • Whittom, F.1    Jobin, J.2    Simard, P.M.3    Leblanc, P.4    Simard, C.5    Bernard, S.6    Belleau, R.7    Maltais, F.8
  • 64
    • 3142517968 scopus 로고    scopus 로고
    • Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis
    • Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-580.
    • (2004) Thorax , vol.59 , pp. 574-580
    • Gan, W.Q.1    Man, S.F.2    Senthilselvan, A.3    Sin, D.D.4
  • 65
    • 30844447198 scopus 로고    scopus 로고
    • Elevated CRP levels mark metabolic and functional impairment in advanced COPD
    • Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Elevated CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006;61:17-22.
    • (2006) Thorax , vol.61 , pp. 17-22
    • Broekhuizen, R.1    Wouters, E.F.2    Creutzberg, E.C.3    Schols, A.M.4
  • 68
    • 0037465734 scopus 로고    scopus 로고
    • Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease
    • Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-1519.
    • (2003) Circulation , vol.107 , pp. 1514-1519
    • Sin, D.D.1    Man, S.F.2
  • 69
    • 0029787450 scopus 로고    scopus 로고
    • Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease
    • Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996;51(8):819-824.
    • (1996) Thorax , vol.51 , Issue.8 , pp. 819-824
    • Schols, A.M.1    Buurman, W.A.2    Staal Van Den Brekel, A.J.3    Dentener, M.A.4    Wouters, E.F.5
  • 72
    • 0034469421 scopus 로고    scopus 로고
    • Mechanisms of bone loss in inflammatory arthritis: Diagnosis and therapeutic implications
    • Goldring SR, Gravallese EM. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2000;2:33-37.
    • (2000) Arthritis Res , vol.2 , pp. 33-37
    • Goldring, S.R.1    Gravallese, E.M.2
  • 74
    • 17244373523 scopus 로고    scopus 로고
    • The relationship between reduced lung function and cardiovascular mortality: A population-based study and a systematic review of the literature
    • Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005;127:1952-1959.
    • (2005) Chest , vol.127 , pp. 1952-1959
    • Sin, D.D.1    Wu, L.2    Man, S.F.3
  • 75
    • 0030752487 scopus 로고    scopus 로고
    • Oxidative stress in chronic obstructive pulmonary disease
    • Oxidative Stress Study Group
    • Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 1997;156:341-357.
    • (1997) Am J Respir Crit Care Med , vol.156 , pp. 341-357
    • Repine, J.E.1    Bast, A.2    Lankhorst, I.3
  • 77
    • 0037485683 scopus 로고    scopus 로고
    • Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients
    • Hageman GJ, Larik I, Pennings HJ, Haenen GR, Wouters EF, Bast A. Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. Free Radic Biol Med 2003;35:140-148.
    • (2003) Free Radic Biol Med , vol.35 , pp. 140-148
    • Hageman, G.J.1    Larik, I.2    Pennings, H.J.3    Haenen, G.R.4    Wouters, E.F.5    Bast, A.6
  • 79
    • 0036855413 scopus 로고    scopus 로고
    • Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats
    • Chiarugi A. Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. Br J Pharmacol 2002;137:761-770.
    • (2002) Br J Pharmacol , vol.137 , pp. 761-770
    • Chiarugi, A.1
  • 81
    • 0033485301 scopus 로고    scopus 로고
    • Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages: A self-protective mechanism?
    • Grant RS, Passey R, Matanovic G, Smythe G, Kapoor V. Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages: a self-protective mechanism? Arch Biochem Biophys 1999;372:1-7.
    • (1999) Arch Biochem Biophys , vol.372 , pp. 1-7
    • Grant, R.S.1    Passey, R.2    Matanovic, G.3    Smythe, G.4    Kapoor, V.5
  • 82
    • 0025155689 scopus 로고
    • Adaptive changes in NAD+ metabolism in ultraviolet light-irradiated murine lymphoma cells
    • Kleczkowska HE, Szumiel I, Althaus FR. Adaptive changes in NAD+ metabolism in ultraviolet light-irradiated murine lymphoma cells. Cell Biol Toxicol 1990;6:259-268.
    • (1990) Cell Biol Toxicol , vol.6 , pp. 259-268
    • Kleczkowska, H.E.1    Szumiel, I.2    Althaus, F.R.3
  • 83
    • 0031889510 scopus 로고    scopus 로고
    • Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease
    • Pouw EM, Schols AM, van der Vusse GJ, Wouters EF. Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:453-457.
    • (1998) Am J Respir Crit Care Med , vol.157 , pp. 453-457
    • Pouw, E.M.1    Schols, A.M.2    Van Der Vusse, G.J.3    Wouters, E.F.4
  • 84
    • 0023951085 scopus 로고
    • Respiratory muscles and dyspnea
    • Killian KJ, Jones NL. Respiratory muscles and dyspnea. Clin Chest Med 1988;9:237-248.
    • (1988) Clin Chest Med , vol.9 , pp. 237-248
    • Killian, K.J.1    Jones, N.L.2
  • 85
    • 0029118877 scopus 로고
    • Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: A placebo-controlled randomized trial
    • Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: a placebo-controlled randomized trial. Am J Respir Crit Care Med 1995;152:1268-1274.
    • (1995) Am J Respir Crit Care Med , vol.152 , pp. 1268-1274
    • Schols, A.M.1    Soeters, P.B.2    Mostert, R.3    Pluymers, R.J.4    Wouters, E.F.5
  • 86
    • 0037317984 scopus 로고    scopus 로고
    • Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease
    • Creutzberg EC, Wouters EF, Mostert R, Weling-Scheepers CA, Schols AM. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 2003;19:120-127.
    • (2003) Nutrition , vol.19 , pp. 120-127
    • Creutzberg, E.C.1    Wouters, E.F.2    Mostert, R.3    Weling-Scheepers, C.A.4    Schols, A.M.5
  • 87
    • 3242772924 scopus 로고    scopus 로고
    • High-sensitivity C-reactive protein: Clinical importance
    • Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004;29:439-493.
    • (2004) Curr Probl Cardiol , vol.29 , pp. 439-493
    • Bassuk, S.S.1    Rifai, N.2    Ridker, P.M.3
  • 88
    • 0037446333 scopus 로고    scopus 로고
    • Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress
    • Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic Biol Med 2003;34:1006-1016.
    • (2003) Free Radic Biol Med , vol.34 , pp. 1006-1016
    • Komatsu, W.1    Ishihara, K.2    Murata, M.3    Saito, H.4    Shinohara, K.5
  • 89
  • 90
    • 0024406369 scopus 로고
    • Final report on the aspirin component of the ongoing Physicians' Health Study
    • Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-135.
    • (1989) N Engl J Med , vol.321 , pp. 129-135
  • 92
    • 0032562005 scopus 로고    scopus 로고
    • Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
    • The Medical Research Council's General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 1998;351:233-241.
    • (1998) Lancet , vol.351 , pp. 233-241
  • 93
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • HOT Study Group
    • Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-1762.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlof, B.4    Elmfeldt, D.5    Julius, S.6    Menard, J.7    Rahn, K.H.8    Wedel, H.9    Westerling, S.10
  • 94
    • 0035852471 scopus 로고    scopus 로고
    • Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
    • Collaborative Group of the Primary Prevention Project
    • de Gaetano G. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001;357:89-95.
    • (2001) Lancet , vol.357 , pp. 89-95
    • De Gaetano, G.1
  • 96
    • 17244371786 scopus 로고    scopus 로고
    • Can inhaled steroids mend a broken heart in chronic obstructive pulmonary disease?
    • Sin DD, Man SF. Can inhaled steroids mend a broken heart in chronic obstructive pulmonary disease? Eur Respir J 2005;25:589-590.
    • (2005) Eur Respir J , vol.25 , pp. 589-590
    • Sin, D.D.1    Man, S.F.2
  • 97
    • 0023938335 scopus 로고
    • The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response
    • Kammer GM. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 1988;9:222-229.
    • (1988) Immunol Today , vol.9 , pp. 222-229
    • Kammer, G.M.1
  • 98
    • 0035188826 scopus 로고    scopus 로고
    • Cyclic nucleotide phosphodiesterases
    • Essayan DM. Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol 2001;108:671-680.
    • (2001) J Allergy Clin Immunol , vol.108 , pp. 671-680
    • Essayan, D.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.